Odyssey Therapeutics, Inc.
CIK:
0001882782
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
other
State of Incorporation
DE
Business Address
51 SLEEPER STREET, BOSTON, MA, 02210
Mailing Address
51 SLEEPER STREET, BOSTON, MA, 02210
Phone
(212) 841-1000
Fiscal Year End
1231
EIN
863384382
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-1 IPO registration statement | April 17, 2026 | View on SEC |
IPO Filings
S-1
April 17, 2026
- Focus on 'undruggable' protein targets in immune and cancer pathways
- Proprietary AI-driven platform for rapid drug discovery and structural design
Related Companies
Companies in the same industry (SIC: 2836)
Passage BIO, Inc.
PASG
Biological Products, (No Diagnostic Substances)
Ginkgo Bioworks Holdings, Inc.
DNA
Biological Products, (No Diagnostic Substances)
CG Oncology, Inc.
CGON
Biological Products, (No Diagnostic Substances)
Aura Biosciences, Inc.
AURA
Biological Products, (No Diagnostic Substances)
COGNITION THERAPEUTICS INC
CGTX
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.